Changeflow GovPing Government & Legislation National Health Chemotherapy Funding Amendment
Routine Rule Amended Final

National Health Chemotherapy Funding Amendment

Favicon for www.legislation.gov.au AU Federal Legislative Instruments (7-day)
Published
Detected
Email

Summary

The Australian Department of Health, Disability and Ageing issued Instrument F2026L00404 amending the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024. This April 2026 update modifies chemotherapy drug schedules and funding arrangements under the National Health Act 1953, affecting reimbursement rates and coverage for cancer treatments.

Published by DoH AU on legislation.gov.au . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .
View original document View source feed page

What changed

The amendment modifies the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024 (PB 31 of 2024), updating the efficient funding schedule for chemotherapy drugs and related services. Changes may include updated drug prices, amended infusion service fees, revised medicine benefit listings, or adjusted access criteria for specific chemotherapy agents.

Healthcare providers administering chemotherapy and pharmaceutical companies supplying chemotherapy medicines should review the updated Schedule 1 amendments to ensure alignment with current billing codes and reimbursement rates. The instrument takes effect 31 March 2026, with any pricing or listing changes impacting PBS claiming from the effective date. Providers should verify their systems reflect the updated arrangements before submitting claims.

What to do next

  1. Review Schedule 1 amendments to the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024
  2. Update billing and claiming systems with revised chemotherapy drug prices and infusion fees
  3. Verify reimbursement rates align with the new efficient funding schedule before submitting claims from 31 March 2026

Archived snapshot

Mar 31, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

- Interactions

National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment (April Update) Instrument 2026

In force Administered by
- Department of Health, Disability and Ageing
This item is authorised by the following title:

View document Legislative instrument Explanatory statement Filter active Table of contents
- 1. Name
- 2. Commencement
- 3. Authority
- 4. Schedules
- Schedule 1—Amendments
- National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024 (PB 31 of 2024)

Named provisions

National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024 Schedule 1—Amendments Commencement Authority

Related changes

Favicon for www.legislation.gov.au National Health Act - Commonwealth Pharmaceutical Benefits Pricing Determination 2019 (April 2026)
Routine Apr 17, 2026 • AU Federal Legislative Instruments (7-day) • Government & Legislation
Favicon for www.fedcourt.gov.au Wilson v State of Victoria - Costs Appeal Refused
Priority review Apr 17, 2026 • Australia Federal Court Latest Judgments • Courts & Legal
Favicon for www.tga.gov.au Three Victorians Arrested, $2M Steroids and Peptides Seized in Joint ABF-TGA Operation
Routine Apr 17, 2026 • TGA Australia Media Releases • Pharma & Drug Safety

Get daily alerts for AU Federal Legislative Instruments (7-day)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Source

Favicon for www.legislation.gov.au
AU Federal Legislative Instruments (7-day) legislation.gov.au/search/registrationdate(today-7,today)/collection(LegislativeInstrument)/sort(registeredat%20desc)
Government & Legislation

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from DoH AU.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Press inquiries →

Classification

Agency
DoH AU
Published
March 31st, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
F2026L00404
Supersedes
National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024 (PB 31 of 2024)

Who this affects

Applies to
Healthcare providers Pharmaceutical companies Public health authorities
Industry sector
6211 Healthcare Providers 3254 Pharmaceutical Manufacturing 6221 Hospitals & Health Systems
Activity scope
Chemotherapy drug funding Medical service reimbursement Pharmaceutical Benefits Scheme claiming
Geographic scope
Australia AU

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Pharmaceuticals Public Health

Browse Categories

Agriculture & Food Safety 65 AI Regulation 3 Banking & Finance 332 Consumer Protection 63 Courts & Legal 361 Data Privacy & Cybersecurity 77 Defense & National Security 51 Education 44 Energy 100 Environment 86 Environmental & Energy 36 Environmental Regulation 7 Financial Regulation 2 Government & Legislation 278 Government Operations 107 Healthcare 136 Healthcare Compliance 6 Healthcare & Life Sciences 72 Housing 16 Immigration 8 Immigration & Border Control 2 Insurance 66 Labor & Employment 126 Legal & Judicial 29 Pharma & Drug Safety 101 Pharma & Healthcare 1 Privacy 1 Public Health 2 Real Estate & Housing 61 Sanctions & Export Controls 1 Securities & Investments 28 Securities & Markets 103 Securities Regulation 6 Tax 64 Tax & Revenue 9 Telecom & Technology 47 Trade & Commerce 3 Trade & Sanctions 135 Transportation 85

Get alerts for this source

We'll email you when AU Federal Legislative Instruments (7-day) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!